TL;DR

• According to Axios, OpenAI is in early discussions with the Trump administration, with a proposal that may involve transferring about 5% equity to a public wealth fund.
• The disagreement is whether the government will just receive economic benefits or if it will also have the ability to influence company governance through voting rights and board seats.
• Related entities: OpenAI, Microsoft, NVIDIA, Google, Meta.

According to an Axios report on July 2, OpenAI is in early discussions with the Trump administration, with a proposal that may involve transferring about 5% of equity to a vehicle similar to a public wealth fund, allowing the American public to share in the benefits of AI growth. No deal has been reached yet, nor has OpenAI or the White House made any formal announcements.

This figure is not small. OpenAI announced on March 31 that it completed $122 billion in funding, with a post-money valuation of $852 billion. Based on this metric, 5% corresponds to about $42.6 billion. It is not a symbolic donation, but a financial interest substantial enough to change the way policy discussions are conducted.

Investors are concerned not about whether the American public will quickly receive AI dividends, but whether regulators, as frontier models increasingly touch on issues of national security, employment impact, and social governance, will shift from being external approvers to co-beneficiaries of the company's growth.

This is also the core of the divergence between Altman and U.S. Senator Bernie Sanders. OpenAI's idea is to exchange a smaller percentage of economic equity for public sharing and political buffering. Sanders' proposal in June was more radical, calling for a one-time 50% stock tax on large AI companies and allowing the government to influence company decisions through voting shares.

The 5% discussion stems from preemptive policy risks

Cutting-edge AI is no longer just a commercial product; it falls under the scope that the U.S. government believes must be intervened in early.

For ordinary investors, the release of the model can be understood as a "new drug entering the market." The company believes the product is ready, and the market is waiting for new features to bring subscriptions, enterprise customers, and ecosystem growth, but the government will care about safety testing, social impact, and national competitiveness.

This pressure has already manifested around the release arrangements for GPT-5.6. AP reported that OpenAI, at the request of the Trump administration, restricted GPT-5.6 Sol to approved customers only. OpenAI's official wording is more moderate, stating that this is a phased release requiring additional testing and coordination.

This cannot be written as "the government stalling the product, so OpenAI traded equity for release." There is no public trading relationship between the two. However, the timeline indicates that policy friction has already begun to affect product pace, customer scope, and commercialization expectations.

OpenAI's high valuation is based on leading models, rapid product iteration, and commercial expansion. If the release of key models requires waiting for administrative coordination, investors will consider policy discounts. Conversely, if the company can include the government in the revenue-sharing structure, the market may also reassess the extent of that discount.

Thus, the market implications of the 5% proposal are not a short-term positive for a certain version release. It resembles OpenAI's attempt to transform the regulatory relationship from an external constraint into a form of aligned interest. This change will affect how risks are priced across Microsoft, NVIDIA, and the broader AI chain, but it is still just early speculation.

Altman and Sanders are arguing over control

Public wealth funds are not complex. In simple terms, it means the government takes the revenue generated from a certain public resource and puts it into an investment pool, then returns part of the revenue to the public. OpenAI's April policy document proposed the Public Wealth Fund, aiming to let citizens who do not participate in financial market investments share in the benefits of AI growth.

Altman's idea is to view AI as a public asset that can generate immense social returns. If leading labs put a small portion of equity into the public fund, ordinary people, even if they cannot buy OpenAI stock, can indirectly benefit from AI's growth.

However, equity does not equal control. Equity can be merely an economic interest, or it can come with voting rights. The former is more akin to dividend rights, where the government receives benefits but does not directly intervene in company decisions. The latter may influence the board, major transactions, and corporate strategy.

Sanders' proposal directly targets control. The core of his American AI Sovereign Wealth Fund Act proposes a one-time 50% stock tax on large AI companies and inclusion in the fund. Its public explanation mentions that the fund will be managed by an independent committee and will use voting shares to influence company decisions.

In a column on June 3, Sanders explicitly stated that the government should obtain voting shares and have equal representation on the boards of relevant companies. His logic is that AI will affect employment, wealth distribution, and public safety, and cannot be solely decided by a few tech companies.

In contrast, OpenAI's 5% discussion appears to be a proactive compromise. It acknowledges that the public should share in AI dividends but seeks to avoid directly handing over governance to the government. For investors, the most critical distinction is the structure of rights. If the 5% ends up being merely economic interest without voting rights, it resembles a cost of political buffering. If it comes with governance rights, it signifies a change in the company's control structure.

Government equity stakes will change risk dynamics

The most optimistic interpretation is that after becoming economic beneficiaries, the government will be more willing to support the expansion of U.S. AI companies. If regulators can also benefit from OpenAI's appreciation, they may prioritize product releases, capital market pathways, and global competitiveness more highly.

But regulatory risks will not disappear as a result. The government, being both a regulator and a shareholder, will introduce new conflicts of interest. It may loosen scrutiny because of its holdings, or it may intervene more deeply in company decisions due to political goals. Both scenarios do not align with pure market logic.

Equating "government equity" with "nationalization" is also an oversimplification. If the 5% equity does not come with voting rights, it is hard to call it government control. However, if the fund's design, voting arrangements, and board rights are not clarified, the market cannot treat it as a mere dividend tool.

For related entities like Microsoft, NVIDIA, Google, and Meta, the impact is not simply short-term orders. A more reasonable understanding is that policy variables in the AI supply chain are being prioritized. In the past, investors mainly considered computing power needs, model capabilities, cloud revenue, and capital expenditures; now they also have to examine how leading labs manage the relationship between public benefits, regulatory authorizations, and national competition.

It is also important to maintain a boundary here. Public reports are more aligned with OpenAI and Altman's hope for leading labs to participate in similar arrangements, which does not equate to Anthropoc, Google, or Meta already entering negotiations. If the mechanism extends to other companies, it could potentially become a new template for U.S. AI governance.

Equity terms and congressional procedures determine pricing

This discussion is still in its early stages, and the most critical variables have yet to materialize. Whether the 5% is common stock, non-voting shares, or some fund rights with special terms will determine whether it serves as policy insurance or a governance entry point.

Congressional procedures are equally crucial. A permanent public wealth fund distributing benefits to the national public will likely require legislative support. Without Congressional authorization, the proposal will struggle to transition from discussions between the company and the government into a sustainable public financial mechanism.

Whether other AI labs follow suit will also impact market pricing. If only OpenAI participates, it resembles the political risk management of a single company. If more leading labs are brought under the same framework, it could become the cost of entry for cutting-edge AI in the U.S.

We cannot write the 5% discussion as a completed transaction, nor can we equate it with the impending release of GPT-5.6. It resembles an early signal: the valuation of cutting-edge AI companies is extending from model capabilities and computational investment to whether political pressures can be managed institutionalized. The real verification points will be whether equity has voting rights, whether the fund receives legislative support, and whether the company can maintain its product release pace.

免责声明：本文章仅代表作者个人观点，不代表本平台的立场和观点。本文章仅供信息分享，不构成对任何人的任何投资建议。用户与作者之间的任何争议，与本平台无关。如网页中刊载的文章或图片涉及侵权，请提供相关的权利证明和身份证明发送邮件到support@aicoin.com，本平台相关工作人员将会进行核查。